No business profile yet.
Size ADARx Pharmaceuticals (ADRX) is a United States Industrials company (Biotechnology) with a market value of $1.43B, the 1999th largest of 3,085 United States companies the cockpit tracks. Shares closed at $12.82 on 18 Nov 2026.
Growth The operating margin is -2,562.1% (peer median 6.9%).
Valuation It trades at 153.9× enterprise value to sales against a peer median of 1.7× (2nd most expensive of 20).
Short interest Short interest is 1.6% of the free float (30 Oct 2026).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Revenue | n/a | $3.45M | $0 |
| Revenue growth | — | — | — |
| Gross profit | n/a | $1.12M | -$1.50M |
| EBITDA | n/a | -$86.0M | -$56.7M |
| Net income | n/a | -$73.1M | -$46.4M |
| Free cash flow | n/a | $259M | -$49.0M |
| Capital expenditure | n/a | $2.94M | $455,000 |
| Total debt | $6.46M | $7.74M | $4.33M |
Peer set: Sector in the same market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ADRX | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -27.5% | -8.8% | 4th lowest of 21 |
| Distance from 52-week high | -44.8% | -38.1% | 7th lowest of 21 |
| Operating margin | -2,562.1% | 6.9% | 2nd lowest of 20 |
| EV / Sales | 153.9× | 1.7× | 2nd most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | -16.9% | 8.5% | least demanding of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals ADRX | United States | $1.43B | n/a | n/a | -2,562% | 153.9× | -16.9% | n/a |
| MillerKnoll MLKN | United States | $1.43B | +38% | +1% | 6% | 0.8× | 7.3% | +9.3% |
| Hub HUBG | United States | $1.44B | -42% | n/a | n/a | n/a | n/a | n/a |
| ICF International ICFI | United States | $1.40B | +14% | -5% | 8% | 1.0× | -2.5% | +4.4% |
| Helios Technologies HLIO | United States | $1.47B | -43% | +12% | 13% | 1.9× | 9.8% | +9.9% |
| Clarivate CLVT | United States | $1.38B | -12% | -9% | 8% | 2.3× | 13.2% | +14.4% |
| Global Ship Lease GSL | United States | $1.47B | -1% | +4% | 48% | 2.0× | -13.7% | +22.1% |
| Cimpress CMPR | United States | $1.37B | -43% | +10% | 6% | 0.8× | 5.6% | +7.7% |
| Cadre CDRE | United States | $1.37B | +9% | +18% | 12% | 2.3× | 15.3% | +8.6% |
| Preformed Line Products PLPC | United States | $1.36B | -17% | +16% | 10% | 1.7× | 11.8% | +7.5% |
| CRA International CRAI | United States | $1.35B | +46% | +13% | 10% | 1.9× | 6.6% | +8.1% |
| JetBlue Airways JBLU | United States | $1.35B | -25% | +10% | -6% | 0.9× | n/a | n/a |
| Costamare CMRE | United States | $1.53B | -28% | -42% | 44% | 3.3× | -6.6% | +13.0% |
| Hillman Solutions HLMN | United States | $1.53B | +9% | +6% | 6% | 1.6× | 17.5% | +2.6% |
| Allient ALNT | United States | $1.32B | +23% | +13% | 10% | 2.5× | 24.9% | +8.6% |
| Tennant TNC | United States | $1.30B | -8% | 0% | 4% | 1.3× | n/a | n/a |
| Alamo ALG | United States | $1.60B | -14% | +2% | 7% | 1.0× | 7.2% | +6.6% |
| NuScale Power SMR | United States | $1.61B | -62% | -96% | -9,493% | 229.2× | n/a | n/a |
| ERock EROC | United States | $1.61B | n/a | +43% | -19% | 7.2× | 15.0% | +42.5% |
| Werner Enterprises WERN | United States | $1.62B | -32% | +15% | 2% | 0.8× | n/a | n/a |
| Distribution Solutions DSGR | United States | $1.62B | +29% | +7% | 4% | 1.1× | n/a | n/a |